Skip to main content
All lobbying filings

Kelley Drye & Warren LLP

Kelley Drye & Warren LLP filed a Q2 report for Laboratory Corporation of America Holdings on July 20, 2026, reporting $110,000 in lobbying income.

Lobbying for Laboratory Corporation of America Holdings · Clinical laboratory

As filed: KELLEY DRYE & WARREN LLP for LABORATORY CORPORATION OF AMERICA HOLDINGS.

All filings by Kelley Drye & Warren LLP · Everything Laboratory Corporation of America Holdings has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$110,000
What the client paid this registrant for the period.
Client based in
North Carolina

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, and H.R. 9393, the Lower Costs, More Transparency Act, provisions relating to lab test price transparency; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.

 Bills named in this filing 6

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem